Coca-Cola posted a 10 percent increase in fourth-quarter revenue to $9.5 billion, boosted by its $5.6 billion acquisition of sports performance and hydration drinks, BodyArmor.
The soda company’s hydration, sports, coffee, and tea segment grew 12 percent for the quarter, with sports drinks growing 18 percent.
According to Coke, BodyArmor was the No. 2 sports drink in the US in 2021 based on measured retail channels.
Coke acquired the remaining 85 percent shares of BodyArmor that it didn’t own in November.
BodyArmor will be managed as a separate business within Coca-Cola’s North America operating unit.
In 2021, Coke’s revenue soared 17 percent to $38.7 billion, with operating income dropping l 15 percent due to the “timing of concentrate shipments.”
Coca-Cola expects organic revenue growth of 7 to 8 percent in 2022 and commodity price inflation to be in the “mid-single-digit percentage.”
Meanwhile, Coca-Cola’s rival Pepsi recorded a fourth-quarter revenue of $25.25 billion, beating analysts’ estimates of $24.24 billion. It expects a 6 percent revenue growth in 2022.
Pepsi CEO Ramon Laguarta revealed that they expanded production capacity for its Gatorade sports drink, reportedly hit by supply chain issues related to bottle supply.
Both Coke and Pepsi attributed some of their revenue success to price hikes.


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



